- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Alnylam Pharmaceuticals Inc+ Add to Watchlist
ALNY:US57.3600 USD 0.4900 0.85%
As of 20:10:00 ET on 07/11/2014.
Company Profile for Alnylam Pharmaceuticals Inc (ALNY)
Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
Alnylam Pharmaceuticals Inc
Key Executives for Alnylam Pharmaceuticals Inc (ALNY)
|John M MaraganoreChief Executive Officer||Barry E GreenePresident/COO|
|Akshay K VaishnawExec VP/Chief Medical Officer||Laurence E ReidSenior VP/Chief Business Ofcr|
|Michael P MasonVP:Finance/Treasurer||Cynthia ClaytonVP:Investor Relations|